Vannucchi, A. M., Verstovsek, S., Guglielmelli, P., Griesshammer, M., Burn, T. C., Naim, A., . . . Kiladjian, J. (2017). Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study. Ann Hematol.
Chicago-tyylinen lähdeviittausVannucchi, Alessandro Maria, et al. "Ruxolitinib Reduces JAK2 P.V617F Allele Burden in Patients With Polycythemia Vera Enrolled in the RESPONSE Study." Ann Hematol 2017.
MLA-viiteVannucchi, Alessandro Maria, et al. "Ruxolitinib Reduces JAK2 P.V617F Allele Burden in Patients With Polycythemia Vera Enrolled in the RESPONSE Study." Ann Hematol 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.